The subscription price for the warrants of series TO6 in Svenska Aerogel Holding AB (publ) has been determined to SEK 0.22 and the exercise period starts May 2, 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SOUTH AFRICA, SOUTH KOREA, BELARUS, RUSSIA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Svenska Aerogel Holding AB (publ) (“Svenska Aerogel” or “the Company”) completed a rights issue of units on Nasdaq First North Growth Market in October 2022. Each unit consisted of two (2) shares and two (2) warrants of series TO6. Each warrant of series TO6 entitles to subscribe for one (1) new share in the Company. The exercise price for the warrants of series TO6 have been determined to 70 percent of the volume-weighted average price in the Company’s share on Nasdaq First North Growth Market during the measurement period, which ran from and including April 14, 2023, up to and including April 27, 2023, however not higher than SEK 0.22 and not less than the quota value of the Company’s shares. During the measurement period, the volume-weighted average price in the Company’s share was approximately SEK 0.40, therefore, the exercise price for the warrants of series TO6 is SEK 0.22. The exercise period for warrants of series TO6 runs during the period from and including May 2, 2023, up to and including May 16, 2023.
If all the warrants of series TO6 are exercised, the Company will receive approximately SEK 29.0 million before issuing costs. For the warrants to not expire without value, it is required that the holder actively subscribes for new shares no later than May 16, 2023, or sell the warrants no later than May 12, 2023. Please observe that certain nominees might close their application earlier than May 16, 2023.
Summarized terms for the warrants of series TO6:
Exercise period: May 2, 2023– May 16, 2023.
Issue size: 131,826,368 warrants of series TO6, which entitles to subscription of 131,826,368 shares. If all warrants are exercised, the Company will receive approximately SEK 29.0 million before issuing costs.
Exercise price: SEK 0.22 per share.
Last day for trading warrants of series TO6: May 12, 2023.
Share capital and dilution: If all warrants are exercised the share capital will increase with SEK 6,591,318.40, from SEK 19,891,248.25 to SEK 26,482,566.65. If all warrants are exercised the number of shares and votes in the Company will increase with 131,826,368 shares, from 397,824,965 shares to 529,651,333 shares. In the event that all warrants of series TO6 are exercised, the dilution amounts to approximately 25 percent of the number of shares and votes in the Company.
Please note that warrants that are not exercised no later than May 16, 2023, or sold no later than May 12, 2023, will expire without value. For warrants not to lose their value, the holder must actively subscribe for new shares or sell the warrants.
How warrants are exercised:
Nominee-registered warrants (Custody account)
Subscription and payment by exercise of warrants shall be made in accordance with instructions from each nominee. Please contact your nominee for additional information.
Direct-registered warrants (Securities account)
No accounts for issuing nor any instructions regarding payments will be sent out. Subscriptions will be made through simultaneous payment in accordance with the instructions on the application form. The warrants will then be replaced by interim shares awaiting registration at the Swedish Companies Registration Office.
The application form including instructions for payment will be available at the Company’s website, www.aerogel.se, and on Mangold Fondkommission AB’s website, www.mangold.se.
Mangold Fondkommission AB is financial adviser and Eversheds Sutherland is legal adviser to Svenska Aerogel in connection with the exercise period of the warrants of series TO6.
For further information, please contact:
Tor Einar Norbakk, CEO. Telephone: +46 (0)70 616 08 67. E-mail: email@example.com
About Svenska Aerogel Holding AB (publ)
Svenska Aerogel manufactures and commercializes the mesoporous material Quartzene®. Svenska Aerogel’s business concept is to meet the market’s need for new materials that are in line with global sustainability objectives. Quartzene® is flexible and can be tailored to different applications to add essential properties to an end product. The company’s vision is to be the most valued business partner providing pioneering material solutions for a sustainable world.
Svenska Aerogel Holding AB is listed on Nasdaq First North Growth Market. Certified Adviser is FNCA, firstname.lastname@example.org, +46 8-528 003 99.
Gävle, 28 April 2023
The release, announcement or distribution of this press release may, in certain jurisdictions, be subject to restrictions. The recipients of this press release in jurisdictions where this press release has been published or distributed shall inform themselves of and follow such restrictions. The recipient of this press release is responsible for using this press release, and the information contained herein, in accordance with applicable rules in each jurisdiction. This press release does not constitute an offer, or a solicitation of any offer, to buy or subscribe for any securities in Svenska Aerogel in any jurisdiction, neither from Svenska Aerogel nor anyone else.
This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities in the United States. The securities referred to herein may not be sold in the United States absent registration or an exemption from registration under the US Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States. The information in this press release may not be announced, published, copied, reproduced or distributed, directly or indirectly, in whole or in part, within or into Australia, Hong Kong, Japan, Canada, New Zealand, Switzerland, South Africa, the United States, Belarus, Russia or in any other jurisdiction where such announcement, publication or distribution of the information would not comply with applicable laws and regulations or where such actions are subject to legal restrictions or would require additional registration or other measures than what is required under Swedish law. Actions taken in violation of this instruction may constitute a crime against applicable securities laws and regulations.